Bullous pemphigoid (BP) is an autoimmune disease characterized by subepidermal vesicles and the presence of autoantibodies directed against the epidermal basement membrane zone. Previous studies have identified two protein components of the hemidesmosome, BP180 and BP230, as the primary antigenic targets of BP autoantibodies. We have recently reported the isolation of a 1.0-kb BP180 cDNA. Sequence analysis presented in this report reveals that this partial BP180 cDNA encodes two protein domains which have primary structures that are characteristic of the triple helical domains of collagens, i.e., glycine appears at every third position and over one-third of the remaining residues are proline. The two collagen domains have lengths of 242 and 30 amino acids and are separated by a noncollagen stretch of 12 amino acids. Collagenase digestion of the BP180 cDNA-encoded fusion protein generated a peptide fragment with a size that was consistent with the predicted locations of the collagenase digestion sites. A possible physiological function for the collagen domains of the BP180 hemidesmosomal protein may be to form stable interactions with constituents of the extracellular matrix of the cutaneous basement membrane zone. Such interactions may provide the molecular framework for the adhesion between the basal keratinocyte and the basal lamina. (J. Clin. Invest. 1991.87:734-738.) 
Introduction
The hemidesmosome is a plasma membrane-associated organelle found in basal cells of stratified, squamous epithelia and is thought to be involved in the attachment of the epithelium to the underlying basal lamina. It appears that a disruption of the function of the hemidesmosome may play a role in the pathogenesis of the blistering skin disorder, bullous pemphigoid (BP).' The hallmark ofthis disease is the appearance of subepi-dermal vesicles caused by the detachment of the epidermal basal cell layer from the basal lamina at the level of the lamina lucida. In the skin lesions of BP patients, hemidesmosomes cannot be visualized by electron microscopy (1, 2) . Immunoelectron microscopic studies have demonstrated that circulating BP autoantibodies bind specifically to the hemidesmosomes of normal epidermis (3) (4) (5) (6) (7) ; however, it is important to note that direct evidence ofthe pathogenicity ofthese antihemidesmosomal autoantibodies is lacking.
Immunoblot and immunoprecipitation analyses have demonstrated that two large epidermal polypeptides, BP230 and BP 180, are the major antigenic moieties recognized by BP autoantibodies (8) (9) (10) (11) . Recent studies dealing with the characterization of these autoantibodies have employed a molecular genetic approach involving the identification of BP antigen cDNA clones from a human keratinocyte cDNA expression library with the use of a serum from a BP patient (12, 13) . Using this strategy, Stanley and co-workers (12) cloned and characterized a human epidermal cDNA which corresponds to a portion of the 230-kD BP antigen, BP230. Sequence analysis revealed a 1,992-bp open reading frame encoding a 76-kD peptide corresponding to the carboxy terminus of BP230. Northern analysis demonstrated that the BP230 probe hybridized to a 9-kb transcript.
More recently, our laboratory has reported the isolation of partial cDNA clones corresponding to both the BP230 (previously referred to as BP240) and BP 180 human epidermal antigens (13 
Methods
Isolation and characterization ofthe BPJ80 cDNA clone. As described in a previous report (13) 37°C . The reactions were stopped by incubating at 95°C for 2 min in I xSDS gel sample buffer. As a means of testing the specificity of the collagenase preparation, digestions were performed under the conditions described above on 30-jug aliquots of rat tail collagen type I (Collaborative Research, Inc., Bedford, MA) and BSA (Sigma Chemical Co., St. Louis, MO). Other controls included running the reactions after inactivation of the collagenase, either by preboiling the enzyme for 2 min or by adding 25 mM EDTA to the reaction mixture in place of the CaCl2.
SDS-PAGE and immunoblotting procedures. The SDS-PAGE and immunoblotting procedures performed in this study were minor modifications of the procedures described previously by Burnette (20) , Labib et al. (10) , and Morrison et al. (21) . Briefly, the collagenase-digested BP180 lysogen extract and the control digestions were fractionated by SDS-PAGE according to the protocol of Laemmli (22) . The fractionated proteins were electrophoretically transferred to nitrocellulose paper and then probed with a BP serum at a dilution of 1:400 in 4% PTX buffer (0.01 M phosphate, pH 7.5, 0.2% Triton X-100, 0.15 M NaCl, and I mM EGTA). Bound antibodies were detected using 1251 Staphylococcus aureus protein A instead ofthe enzymatic method used by Labib et al. (10) Fig. 1 by the nonshaded box) . The proline content within the collagen regions was found to be quite high, (22% in collagen domain I and 40% in collagen domain II). These prolines are evenly distributed between the "X" and "Y" positions in the Gly-X-Y tripeptide repeat in both collagen domains.
Collagenase digestions. To further document the existence of a collagen structure within the cloned portion of BPI 80, the lysogen extract containing the BP180 cDNA-encoded fusion protein was digested with bacterial collagenase under various conditions and analyzed by SDS-PAGE (Fig. 2, lanes 1-5) and by immunoblotting with a BP serum (Fig. 2, lanes 6-10) .
At time zero the lambda BP 180 lysogen extract contained a major product of 135 kD and a minor one of 146 kD, both of which reacted on an immunoblot with a BP serum (Fig. 2 
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937 CCA GGC CCO CCA GGA CCT COT CGA GCC ATG GGA CCC CCA GGA OCT CCA GGT GOC CCA GGO COT CC OGG CCA 313 (Fig. 2, lanes 4 and 9) , or by boiling the enzyme for 2 min before adding it to the lysogen extract (lanes 5 and 10) . The PAGE and immunoblot analyses of the products of these control reactions gave patterns which, as expected, were identical to those ofthe zero time point. Digestions ofrat collagen type I and BSA were used to test the specificity of the collagenase. A 2-h incubation at 370C with 1 BTC unit ofcollagenase resulted in complete digestion of 30 ug of rat collagen, whereas a 30-,ug aliquot of BSA showed no detectable degradation after collagenase treatments lasting up to 24 h (data not shown).
Discussion
The sera of BP patients contain autoantibodies which bind hemidesmosomal antigens of squamous epithelia (3-7) and react by immunoblotting and immunoprecipitation with two large epidermal proteins, i.e., the BP230 and the BPI80 antigens (8) (9) (10) (11) . Stanley et al. (12) were the first to clone a cDNA corresponding to one of the BP antigens, a clone which was shown to encode the COOH-terminal one-third of the BP230 antigen. Sequence analysis has revealed that BP230 shares a significant homology with desmoplakins I and II (23) , components ofthe desmosomal plaque, but does not share homology with other known matrix or structural proteins.
In the present paper we report the sequence of a 1,047-bp human epidermal cDNA which, by immunological criteria, had previously been shown to encode a portion of BPI 80 (13) . This clone corresponds to approximately one-sixth of the size of the BP1 80 transcript previously reported by our laboratory (6 kb; reference 13). No information is available concerning the position of this cloned sequence relative to the 5' or 3' terminus of the BPI 80 RNA transcript; however, because this clone was isolated from an oligo dt-primed library, it is unlikely that it corresponds to a region near the 5' end of this long transcript.
Based on sequence analysis, the fusion protein encoded by the lambda BP180 recombinant clone has a predicted size of 148 kD; however, two fusion protein products were detected in the BPI 80 lysogen extract (see Fig. 2, lanes I and 6) . A 146-kD immunoreactive polypeptide, which may correspond to the intact BP180 fusion protein, was found in low amounts, whereas the major immunoreactive product ofthe BPI 80 clone had an apparent molecular weight of 135 kD. Both bands showed reactivity with a BP serum and with a rabbit anti-beta-galactosidase antiserum. Efforts to eliminate proteolysis during the extraction procedure had no effect on the relative amounts of these two polypeptides, suggesting that both the 146-and the 135-kD polypeptides may be generated by the lysogen in culture.
The BPI 80 sequence showed no significant homology, at either the nucleotide or the amino acid level, with the previously published sequence of BP230 (12) . This information is consistent with the results ofa previous report from our laboratory (13) (24) . The strict conservation ofthe Gly-X-Y pattern in collagens is due to the fact that the repeating glycine residues are positioned within the interior of the collagen triple helix and, because of size restrictions, no other amino acid can be accommodated at these positions.
As a means ofindependently demonstrating the presence of collagen sequences within the cloned segment of BPI 80, the lysogen extract containing the BPI 80 cDNA-encoded fusion protein was assayed for digestion after treatment with collagenase from Clostridium histolyticum. The substrate specificities of the collagenases from this bacterium have been analyzed extensively with the use ofsynthetic peptides (25) (26) (27) (28) . Based on this information, we predicted that complete collagenase digestion ofthe beta-galactosidase-BP180 fusion protein would generate one major collagenase-resistant peptide of 124 kD and a variety of smaller peptides ranging in size from 3 to 39 amino acids. The predicted 124-kD collagenase-resistant fragment consists of a I 14-kD portion of the beta-galactosidase protein and a 95 amino acid stretch (residues 1-95 from Fig. 1 ) encoded by the BP180 cDNA.
Analysis of the products of the BP180 lysogen digestions demonstrated that both the 146-and 135-kD forms of the BP180 fusion protein are substrates for the bacterial collagenase. Furthermore, the observed size of the major collagenase digestion product, 124 kD, corresponded very well with the size predicted from the sequence analysis.
Immunoblot analysis of the collagenase digestion products also revealed information concerning the general location ofan epitope recognized by BP autoantibodies. The 124-kD collagenase digestion product of the BP180 fusion protein reacted, by immunoblot, with a BP serum. This indicated that one or more epitopes recognized by BP autoantibodies against the BPI 80 antigen are present within the first stretch of 95 amino acids encoded by the 5' end of the BP180 cDNA insert. This 95-amino acid region consists ofa 59-amino acid noncollagenous NH2-terminal domain and a 36-amino acid segment of collagen domain I. This observation does not exclude the possibility that BP epitopes are also present on other portions of the BPl80 antigen. A more precise mapping of the BP epitopes encoded by the BPI 80 cDNA is currently under way.
In summary, the BP 1 80 cDNA encodes a 33-kD segment of the BP 180 antigen containing two collagen domains. The physiological role of these collagen domains may be to interact with one or more of the various matrix proteins present in the epi-dermal basement membrane zone, e.g., laminin, fibronectin, collagen (type IV or VII), a proteoglycan, or an integrin. Such molecular interactions could possibly play an essential role in the adherence ofepidermal basal cells to the dermis. Moreover, it is possible that a disruption of such adhesive interactions (autoantibody-mediated or otherwise) may be the trigger for epidermal cell detachment in BP patients. Testing of these hypotheses will be the focus of future investigations.
